35% Surge Just the Beginning? Alnylam’s Stock Poised for Massive Gains on Heart Drug Success.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Alnylam Pharmaceuticals stock recently popped and could continue to move higher on Alnylam Pharmaceuticals' cardiovascular drug announcement.

The post 35% Surge Just the Beginning? Alnylam’s Stock Poised for Massive Gains on Heart Drug Success. appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”